Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

被引:266
|
作者
Heymans, S
Schroen, B
Vermeersch, P
Milting, H
Gao, FY
Kassner, A
Gillijns, H
Herijgers, P
Flameng, W
Carmeliet, P
de Werf, FV
Pinto, YM
Janssens, S
机构
[1] Univ Maastricht, Expt & Mol Cardiol CARIM, Maastricht, Netherlands
[2] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Cardiovasc Surg, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Cardiol, B-3000 Louvain, Belgium
[5] Ruhr Univ Bochum, Univ Klin, Herz & Diabeteszentrum NRW, Erich & Hanna Klessmann Inst Kardiovaskulare Fors, Bad Oeynhausen, Germany
关键词
metalloproteinases; remodeling; hypertrophy; hypertension; collagen;
D O I
10.1161/CIRCULATIONAHA.104.516963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Alterations in the balance of matrix metalloproteinases ( MMPs) and their specific tissue inhibitors (TIMPs) are involved in left ventricular (LV) remodeling. Whether their expression is related to interstitial fibrosis or LV dysfunction in patients with chronic pressure overload - induced LV hypertrophy, however, is unknown. Methods and Results - Therefore, cardiac biopsies were taken in 36 patients with isolated aortic stenosis ( AS) and in 29 control patients without LV hypertrophy. Microarray analysis revealed significantly increased mRNA expression of collagen types I, III, and IV and transcripts involved in collagen synthesis, including procollagen endopeptidase and lysine and proline hydroxylases, in AS compared with control patients. Collagen deposition was greater in AS than in control patients and was most pronounced in AS patients with severe diastolic dysfunction. Cardiac mRNA expression of TIMP-1 and TIMP-2 was significantly increased in AS compared with control patients ( mRNA transcript levels normalized to GAPDH: TIMP-1, 0.67 +/- 0.1 in AS versus 0.37 +/- 0.08 in control patients; TIMP-2, 9.5 +/- 2.6 in AS versus 1.6 +/- 0.4 in control patients; P < 0.05 for both) but did not differ significantly for MMP-1, -2, or -9. Cardiac TIMP-1 and - 2 transcripts were significantly related to the degree of interstitial fibrosis and proportional to diastolic dysfunction in AS patients. Conclusions - Cardiac expression of TIMP-1 and TIMP-2 is significantly increased in chronic pressure-overloaded human hearts compared with controls and is related to the degree of interstitial fibrosis.
引用
收藏
页码:1136 / 1144
页数:9
相关论文
共 50 条
  • [41] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [42] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [43] Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human vascular smooth muscle cells
    Kato, S
    Yasukawa, H
    Fujii, T
    Yamaguchi, M
    Miyagi, N
    Okamoto, K
    Wada, Y
    Miyamoto, T
    Morimatsu, M
    Fox, JC
    CONNECTIVE TISSUE RESEARCH, 2000, 41 (02) : 143 - 153
  • [44] Matrix metalloproteinase-2, -9 and tissue inhibitor metalloproteinase-1 in patients with hypertension before and after doxazosin therapy
    Derosa G.
    Cicero A.F.G.
    D'Angelo A.
    Tinelli C.
    Ciccarelli L.
    Piccinni M.N.
    Pricolo F.
    Salvadeo S.
    Montagna L.
    Fogari E.
    Gravina A.
    Ferrari I.
    Galli S.
    Paniga S.
    Fogari R.
    High Blood Pressure & Cardiovascular Prevention, 2006, 13 (2) : 47 - 52
  • [45] Expression of matrix metalloproteinase-2 and-9 and tissue inhibitor of metalloproteinase-1 and-2 in intraductal and nonintraductal growth type of cholangiocarcinoma
    Chae, KJ
    Rha, SY
    Oh, BK
    Koo, JS
    Kim, YJ
    Choi, J
    Park, C
    Park, YN
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (01): : 68 - 75
  • [46] Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma
    Mautino, G
    Henriquet, C
    Gougat, C
    Le Cam, A
    Dayer, JM
    Bousquet, J
    Capony, F
    LABORATORY INVESTIGATION, 1999, 79 (01) : 39 - 47
  • [47] Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase
    J F Porter
    S Shen
    D T Denhardt
    British Journal of Cancer, 2004, 90 : 463 - 470
  • [48] Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase
    Porter, JF
    Shen, S
    Denhardt, DT
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 463 - 470
  • [49] Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
    Higashimoto, Y
    Yamagata, Y
    Iwata, T
    Okada, M
    Ishiguchi, T
    Sato, H
    Masuda, M
    Itoh, H
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (05) : 885 - 890
  • [50] Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis
    Katoh, N
    Hirano, S
    Suehiro, M
    Ikenaga, K
    Yasuno, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (02): : 283 - 288